Your browser doesn't support javascript.
loading
TGF-ß/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
Webb, Bryan M; Bryson, Benjamin L; Williams-Medina, Eduardo; Bobbitt, Jessica R; Seachrist, Darcie D; Anstine, Lindsey J; Keri, Ruth A.
Afiliación
  • Webb BM; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland Ohio, USA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Bryson BL; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Williams-Medina E; Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland Ohio, USA.
  • Bobbitt JR; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland Ohio, USA.
  • Seachrist DD; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Anstine LJ; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland Ohio, USA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Keri RA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA; Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland Ohio, US
J Biol Chem ; 297(4): 101162, 2021 10.
Article en En | MEDLINE | ID: mdl-34481843
Cyclin-dependent kinase 7 (CDK7) is a master regulatory kinase that drives cell cycle progression and stimulates expression of oncogenes in a myriad of cancers. Inhibitors of CDK7 (CDK7i) are currently in clinical trials; however, as with many cancer therapies, patients will most likely experience recurrent disease due to acquired resistance. Identifying targets underlying CDK7i resistance will facilitate prospective development of new therapies that can circumvent such resistance. Here we utilized triple-negative breast cancer as a model to discern mechanisms of resistance as it has been previously shown to be highly responsive to CDK7 inhibitors. After generating cell lines with acquired resistance, high-throughput RNA sequencing revealed significant upregulation of genes associated with efflux pumps and transforming growth factor-beta (TGF-ß) signaling pathways. Genetic silencing or pharmacological inhibition of ABCG2, an efflux pump associated with multidrug resistance, resensitized resistant cells to CDK7i, indicating a reliance on these transporters. Expression of activin A (INHBA), a member of the TGF-ß family of ligands, was also induced, whereas its intrinsic inhibitor, follistatin (FST), was repressed. In resistant cells, increased phosphorylation of SMAD3, a downstream mediator, confirmed an increase in activin signaling, and phosphorylated SMAD3 directly bound the ABCG2 promoter regulatory region. Finally, pharmacological inhibition of TGF-ß/activin receptors or genetic silencing of SMAD4, a transcriptional partner of SMAD3, reversed the upregulation of ABCG2 in resistant cells and phenocopied ABCG2 inhibition. This study reveals that inhibiting the TGF-ß/Activin-ABCG2 pathway is a potential avenue for preventing or overcoming resistance to CDK7 inhibitors.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Regulación Neoplásica de la Expresión Génica / Regulación hacia Arriba / Factor de Crecimiento Transformador beta / Quinasas Ciclina-Dependientes / Resistencia a Antineoplásicos / Subunidades beta de Inhibinas / Inhibidores de Proteínas Quinasas / Neoplasias de la Mama Triple Negativas / Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Biol Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Regulación Neoplásica de la Expresión Génica / Regulación hacia Arriba / Factor de Crecimiento Transformador beta / Quinasas Ciclina-Dependientes / Resistencia a Antineoplásicos / Subunidades beta de Inhibinas / Inhibidores de Proteínas Quinasas / Neoplasias de la Mama Triple Negativas / Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Biol Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos